In the context of developing more effective anti-MSLN antibodies, understanding the glycan structures associated with MSLN is necessary, as the binding of CA-125 to MSLN, which facilitates metastasis of ovarian tumors, appears to be dependent on glycosylation states of MSLN (16). This evidence concerns the gene MUC16 and ovarian neoplasm.